|Articles|July 1, 2011
- Applied Clinical Trials-07-01-2011
- Volume 20
- Issue 7
Applied Clinical Trials Digital Edition - July 2011
CRO/SPONSOR : Personalized Medicine Development - Role of CROs TRIAL DESIGN : Eye Movements Help Determine Side Effect Profiles SUBJECT RECRUITMENT : Connecting Type 2 Diabetics to Clinical Trials INFORMATION TECHNOLOGY : Cloud Computing Brings Efficiencies to Life Sciences Also in this issue : Biosimilars Development, Funding in Europe, Transforming R&D, Subject Protection in India
Advertisement
Articles in this issue
about 15 years ago
Recruiting Diabetes Subjectsabout 15 years ago
Eyes Play a Focal Role in Researchabout 15 years ago
Fighting for Territory and Funding in Europeabout 15 years ago
Cloud Computing Efficiencyabout 15 years ago
Best Practice for Clinical Monitoringabout 15 years ago
Personalized Medicine Developmentabout 15 years ago
Italian Regulator Prepares for Europe's Top Jobabout 15 years ago
Value of Time and Moneyabout 15 years ago
Transforming R&D Through Open Innovationabout 15 years ago
Biosimilars Development Raises Research QuestionsAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Pauses Real-Time Release of Drug Rejection Letters While Working to Formalize Policy
2
Bringing the Voice of Clinical Practice and Patients into Drug Development
3
ACT Brief: Single Pivotal Trial Stakes, Configurable FSP Strategy, and G-CSF Biosimilar Portfolio Expansion
4
Beyond Eligibility: Making Trust and Behavioral Readiness Actionable in Clinical Trial Recruitment
5